A Study of a Candidate COVID-19 Vaccine (COV001/2)

The Oxford Vaccine Centre’s COVID-19 vaccine trial is being run by the Jenner Institute and Oxford Vaccine Group. It is a phase I/II single-blinded, randomised, multi-centre study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers aged 18-55 years. The vaccine will be administered intramuscularly (IM). The clinical trial is being conducted in collaboration with University Hospital Southampton NHS Trust and NIHR Imperial Clinical Research Facility.

Imperial PI Dr Katrina Pollock
Trial Sponsor University of Oxford
Study type Interventional
Study status Closed to recruitment

Find out more about this study here.

Find out how to participate in this trial here.